Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Liabilities and Shareholders Equity (2016 - 2025)

Chemours has reported Liabilities and Shareholders Equity over the past 12 years, most recently at $7.4 billion for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $7.4 billion for Q4 2025, down 1.69% from a year ago — trailing twelve months through Dec 2025 was $29.8 billion (down 1.42% YoY), and the annual figure for FY2025 was $7.4 billion, down 1.69%.
  • Liabilities and Shareholders Equity for Q4 2025 was $7.4 billion at Chemours, down from $7.5 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for CC hit a ceiling of $8.2 billion in Q4 2023 and a floor of $7.2 billion in Q1 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $7.5 billion (2021), compared with a mean of $7.6 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: increased 8.38% in 2021 and later fell 8.88% in 2024.
  • Chemours' Liabilities and Shareholders Equity stood at $7.6 billion in 2021, then increased by 1.19% to $7.6 billion in 2022, then increased by 7.87% to $8.2 billion in 2023, then dropped by 8.88% to $7.5 billion in 2024, then fell by 1.69% to $7.4 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $7.4 billion (Q4 2025), $7.5 billion (Q3 2025), and $7.5 billion (Q2 2025) per Business Quant data.